Get the Stockscreener App
0.477
3.61%
0.0166
Ainos Inc stock is traded at $0.477, with a volume of 28,696.
It is up +3.61% in the last 24 hours and down -14.82% over the past month.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
See More
Previous Close:
$0.4604
Open:
$0.479
24h Volume:
28,696
Relative Volume:
0.08
Market Cap:
$6.53M
Revenue:
$122.10K
Net Income/Loss:
$-13.77M
P/E Ratio:
-0.6276
EPS:
-0.76
Net Cash Flow:
$-4.79M
1W Performance:
+10.93%
1M Performance:
-14.82%
6M Performance:
-55.00%
1Y Performance:
-20.23%
1-Day Range:
$0.45
$0.479
1-Week Range:
$0.4201
$0.4884
52-Week Range:
$0.40
$4.2899
Ainos Inc Stock (AIMD) Company Profile
Name
Ainos Inc
Sector
Industry
Phone
858-869-2986
Address
AINOS, INC., SAN DIEGO
Compare AIMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AIMD
Ainos Inc
|
0.477 | 6.53M | 122.10K | -13.77M | -4.79M | -0.76 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Ainos Inc Stock (AIMD) Latest News
Ainos, Inc. Reports Q3 Financial Results and Strategic Developments - TipRanks
AIMD Stock Hits 52-Week Low at $0.4 Amid Market Challenges - Investing.com India
AIMDAinos, Inc. Latest Stock News & Market Updates - StockTitan
Ainos (AIMD) Advances VELDONA Trial for Sjogren's: Key IRB Approval Secured, 28 Patents Added | AIMDW Stock News - StockTitan
Ainos, Inc. (NASDAQ:AIMD) Sees Large Decline in Short Interest - Defense World
Ainos Advances Sjögren's Treatment: Key Trial for VELDONA® Gets IRB Green Light | AIMDW Stock News - StockTitan
Ainos Third Quarter 2024 Earnings: US$0.33 loss per share (vs US$0.73 loss in 3Q 2023) - Yahoo Finance
Ainos reports unusual stock activity to regulators - Investing.com India
Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities - WICZ
Ainos reports unusual stock activity to regulators By Investing.com - Investing.com UK
Ainos (AIMD) Alerts SEC to Suspicious Trading Activity, Demands Investigation | AIMDW Stock News - StockTitan
Ainos (OTCMKTS:AIMD) Stock Price Up 14.7% – Here’s Why - Defense World
Ainos Reports Third Quarter 2024 Financial Results - StockTitan
Behcet's syndrome Treatment Market 2034: Clinical Trials, EMA, - openPR
Ainos stock plunges to 52-week low of $0.45 amid steep annual decline - Investing.com
Analyzing CONMED (NYSE:CNMD) & Ainos (OTCMKTS:AIMD) - Defense World
Ainos, Inc. (NASDAQ:AIMD) Short Interest Down 37.6% in October - Defense World
Ainos Expands Patent Portfolio With Strategic Shareholder’s Cutting-Edge Technology Assets - StockTitan
Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast - StockTitan
Ainos Inc. secures exclusive patent rights in new deal - Investing.com
Ainos Inc. secures exclusive patent rights in new deal By Investing.com - Investing.com UK
Ainos (OTCMKTS:AIMD) Stock Price Down 8.7% – Here’s Why - Defense World
Ainos Leverages AI Nose for Safer, Smarter Factories - MSN
Financial Health Report: Ainos Inc (AIMD)’s Ratios Tell a Tale - The Dwinnex
Cutera (CUTR) Stock Drops 5.14% Amid Financial Challenges - GuruFocus.com
Ainos Inc. secures stockholder nod for special stock awards - Investing.com
Ainos planning Phase 3 study of low-dose interferon-alpha for primary Sjögren’s - Sjogren's Syndrome News
AIMDWAinos, Inc. Warrants Latest Stock News & Market Updates - StockTitan
Ainos Inc (AIMD) Stock: A Year of Highs and Lows - The InvestChronicle
Ainos receives IRB nod for HIV-related oral wart trial - Investing.com India
Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA - StockTitan
Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren’s Syndrome - StockTitan
Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options - StockTitan
Esperion Therapeutics (NASDAQ:ESPR) versus Ainos (NASDAQ:AIMD) Critical Analysis - Defense World
Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts - StockTitan
AIMD stock touches 52-week low at $0.45 amid market challenges - Investing.com
Ainos set for clinical trial of HIV treatment at Taiwan hospital - Investing.com
Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA - StockTitan
Financial Review: Ainos (OTCMKTS:AIMD) versus Siemens Healthineers (OTCMKTS:SMMNY) - Defense World
Ainos (NASDAQ:AIMD) Shares Down 6.6% - Defense World
Ainos secures Taiwan patent for antiviral drug VELDONA - Investing.com
Ainos Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention - Lelezard
Ainos to Participate in H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Ainos (OTCMKTS:AIMD) Stock Price Up 6.1% - Defense World
Ainos CEO Highlights AI Nose Achievements and Upcoming 2H 2024 Milestones in Shareholder Letter - PharmiWeb.com
Ainos Inc (AIMD) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Is the Ainos Inc (NASDAQ:AIMD) stock an investment opportunity? - US Post News
Ainos AI Nose achieves 79% accuracy in VOC detection - Investing.com India
Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety - AccessWire
Ainos Inc Stock (AIMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):